Skip to main content

Advertisement

SpringerLink
Log in

The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Objective

To evaluate the effects of MEFV genotypes and the major histocompatibility complex class I chain-related gene A (MICA) triplet repeat polymorphism on the severity and clinical features of familial Mediterranean fever (FMF) and amyloidosis in a group of Turkish FMF patients.

Methods

We evaluated 105 adult FMF patients (with or without amyloidosis, 33 and 72, respectively) along with 107 healthy controls who were neither related to the patients nor had a family history of FMF or Behcet’s disease. After recording the demographic and clinical data, the predominant mutations in the MEFV gene locus (M694V, M680I, V726A, M694I, and E148Q) were investigated by direct sequencing. MICA transmembrane polymorphisms in exon 5 were studied by vertical gel electrophoresis and fragment analysis of the amplicons obtained from MICA locus with appropriate primers.

Results

Earlier age at onset, increased frequency of attacks, arthritis attacks, erysipelas-like erythema, increased severity scores and amyloidosis were significantly more common in M694V homozygous patients compared to the patients not M694V homozygous (P = 0.005, OR 4.55; P = 0.001, OR 7.60; P = 0.003, OR 4.57; P = 0.002, OR 7.58; P = 0.004, OR 5.15 and P = 0.018, OR 3.33, respectively). We did not detect any modifying effects of MICA alleles as an independently risk factor on the amyloidosis development. However, when we examined the effects of MICA alleles on the course of the disease and development of amyloidosis in the M694V homozygous patients, A5 allele had a protective effect against the development of amyloidosis (P = 0.038, ORadj 0.26 with A5 and P = 0.009, ORadj 4.42 without A5).

Conclusion

Though the effects of the MEFV genotypes seem clear, there are definitely other modifying factors or genes on the development of amyloidosis and on the course of the disease. For example, some MICA alleles have a protective effect on the prognostic factors in FMF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Anon (1997) Ancient misses mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 90:797–807

    Google Scholar 

  2. Centola M, Wood G, Frucht DM, Galon J, Aringer M, Farrel C et al (2000) The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 95:3223–3231

    PubMed  CAS  Google Scholar 

  3. Mansfield E, Chae JJ, Komarrow HD, Brotz TM, Frucht DM, Aksentijevich I et al (2001) The familial Mediterranean fever protein, pyrin, associates with microtubules and co-localizes with actin filaments. Blood 98:851–859

    Article  PubMed  CAS  Google Scholar 

  4. Touitou I, Lesage S, McDermott M, Cuısset L, Hoffman H, Dode C, Shoham N, Aganna E, Hugot JP, Wise C, Waterham H, Pugnere D, Demaille J, Sarrauste de Menthhiere C (2004) Infevers: an evolving mutation database for auto-inflammatory syndromes. Hum Mutat 24:194–198

    Article  PubMed  CAS  Google Scholar 

  5. Dewalle M, Domingo C, Rozenbaum M, Ben-Cherit E, Cattan D, Bernot A et al (1998) Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 6:95–97

    Article  PubMed  CAS  Google Scholar 

  6. Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, Reinert P et al (1999) MEFV gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 65:88–97

    Article  PubMed  CAS  Google Scholar 

  7. Tekin M, Yalcinkaya Y, Cakar N, Akar N, Misirlioglu M, Tastan H et al (2000) MEFV mutations in multiplex familial with familial Mediterranean fever: is a particular genotype necessary for amyloidosis? Clin Genet 57:430–434

    Article  PubMed  CAS  Google Scholar 

  8. Yalcınkaya F, Cakar N, Misirlioglu M, Tumer N, Akar N, Tekin M et al (2000) Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation independent amyloidosis. Rheumatology 39:67–72

    Article  PubMed  Google Scholar 

  9. Booth DR, Gillmore JD, Booth SE, Pepys MB, Hawkins PN (1998) Pyrin/marenostrin mutations in familial Mediterranean fever. Q J Med 91:603–606

    CAS  Google Scholar 

  10. Yalcınkaya F, Akar N, Misirlioglu M (1998) Familial Mediterranean fever-amyloidosis and the Val726Ala mutation. N Engl J Med 338:993–994

    Article  PubMed  Google Scholar 

  11. Yalcınkaya F, Topaloglu R, Yilmaz E, Emre S, Erken E, On behalf of the Turkish FMF Study Group (2002) Distribution of MEFV mutations and phenotype analysis in Turkish patients with FMF: a nation wide study (abstract). Clin Exp Rheumatol 20(Suppl 26):S90

    Google Scholar 

  12. Saatci U, Yalcınkaya F, Oner A, Besbas N, Baskin E (2002) On behalf of the Turkish FMF Study Group. Renal involvement in Turkish patients with FMF (abstract). Clin Exp Rheumatol 20(Suppl 26):S89

    Google Scholar 

  13. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F. On behalf of the Turkish FMF Study Group (2005) Familial Mediterranean Fever (FMF) in Turkey: results of a Nationwide Multicenter Study. Medicine 84:1–11

  14. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A (2003) The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and the severity in patients with familial Mediterranean fever. Arthritis Rheum 48:1149–1155

    Article  PubMed  Google Scholar 

  15. Zwirner NW, Fernandez-Vina MA, Stastny P (1998) MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetic 47:139–148

    Article  CAS  Google Scholar 

  16. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL et al (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727–729

    Article  PubMed  CAS  Google Scholar 

  17. Wu J, Song Y, Bakker ABH, Bauer S, Spies T, Lanier LL et al (1999) An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285:730–732

    Article  PubMed  CAS  Google Scholar 

  18. Goto K, Ota M, Ando H, Muziki N, Nakamura S, Inoue K et al (1998) MICA gene polymorphisms and HLA-B27 subtypes in Japanese patients with HLA-B27 associated acute anterior uveitis. Invest Ophtalmol Vis Sci 39:634–637

    CAS  Google Scholar 

  19. Gonzalez S, Martinez-Borra J, Torre-Alonso JC, Gonzalez-Roces S, Sanchez del Rio J, Rodriguez Perez A et al (1999) The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum 42:110–116

    Article  Google Scholar 

  20. Rueda B, Pascual M, Lopez-Nevot MA, Koeleman BPC, Ortega E, Maldonado J et al (2003) Association of MICA-A5.1 allele with susceptibility to celiac disease in a family study. Am J Gastroenterol 98:359–362

    Article  PubMed  CAS  Google Scholar 

  21. Gambelunghe G, Falorni A, Ghaderi M, Laureti S, Tortoioli C, Santeusanio F et al (1999) Microsatellite polymorphism of the MHC class I chain-related gene (MICA-A and MICA-B) genes marks the risk for autoimmune Addison’s disease. J Clin Endocrinol Metab 84:3701–3707

    Article  PubMed  CAS  Google Scholar 

  22. Lee YJ, Huang FY, Wang CH, Lo FS, Tsan KW, Hsu CH et al (2000) Polymorphism in the transmembrane region of the MICA gene and type 1 diabetes. J Pediatr Endocrinol Metab 13:489–496

    PubMed  CAS  Google Scholar 

  23. Hassan AB, Nikitina-Zake L, Padyukov L, Karlsson G, Gupta M, Lundberg IE et al (2003) MICA4/HLA-DRB1*04/TNF1 haplotype is associated with mixed connective tissue disease in Swedish Patients. Hum Immunol 64:290–296

    Article  PubMed  CAS  Google Scholar 

  24. Kawabata Y, Ikegami H, Kawaguchi Y, Fujisawa T, Hotto M, Ueda H et al (2000) Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insuline-dependent) diabetes mellitus. Hum Immunol 61:624–629

    Article  PubMed  CAS  Google Scholar 

  25. Huang F, Lee Y, Chen M, Hsu C, Lin S, Sung T et al (2000) Polymorphisms of transmembrane region of MICA gene and Kawasaki disease. Exp Clin Immunogenet 17:130–137

    Article  PubMed  CAS  Google Scholar 

  26. Mizuki N, Ota M, Kimura M, Ohno S, Ando H, Katsuyama Y et al (1997) Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet’s disease. Proc Natl Acad Sci USA 94:1298–1303

    Article  PubMed  CAS  Google Scholar 

  27. Salvarani C, Boiardi L, Mantovani V, Olivieri I, Ciancio G, Cantini F et al (2001) Association of MICA alleles and HLA-B51 in Italian patients with Behçet’s disease. J Rheumatol 28:1867–1870

    PubMed  CAS  Google Scholar 

  28. Cohen R, Metzger S, Nahir M, Chajek-Shaul T (2002) Association of the MIC-A gene and HLA-B51 with Behçet’s disease in Arabs and non-Ashkenazi Jews in Israel. Ann Rheum Dis 61:157–160

    Article  PubMed  CAS  Google Scholar 

  29. Touitou I, Picot MC, Domingo C, Notarnicola C, Cattan D, Demaille J et al (2001) The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum 44:163–169

    Article  PubMed  CAS  Google Scholar 

  30. Medlej-Hashim M, Delague V, Chouery E, Salem N, Rawashdeh M, Lefranc G et al (2004) Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects. BMC Medical Genetics 5:4 (http://www.biomedcentral.com/1471–2350/5/4)

    Google Scholar 

  31. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885

    Article  PubMed  CAS  Google Scholar 

  32. Pras E, Livneh A, Balow JE Jr, Pras E, Kastner DL, Pras M, et al (1998) Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 75:216–219

    Article  PubMed  CAS  Google Scholar 

  33. Gershoni-Baruch R, Kepten I, Shinawi M, Brik R (1999) Direct detection of common mutations in familial Mediterranean fever gene (MEFV) using naturally occurring and primer mediated restriction fragment analysis. Mutation in brief no. 257. Hum Mutat (Online)

  34. Sayhan N, Ozdoğan H, Kasapcopur O, Melikoglu M, Altıparmak MR, Tunc R, Yazici H, Sonmez M, Tuzuner N, erek E, Arisoy N (2000) MEFV gene analysis in familial Mediterranean fever patients from Turkey: prognostic value of M694V homozygous phenotype [absract]. Clin Exp Rheumatol 18:286

    Google Scholar 

  35. Yilmaz E, Balci B, Kutlay S, Ozen S, Erturk S, Oner A, Besbas N, Bakkaloglu A (2003) Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients. Turk J Pediatr 45:198–202

    PubMed  Google Scholar 

Download references

Acknowledgment

This study is supported by the Foundation of Academic Research Projects of Ankara University (No: 2003-0809093).

Author information

Authors and Affiliations

  1. Department of Clinical Immunology and Rheumatology, School of Medicine, Ankara University, Ankara, Turkey

    Nuran Turkcapar, Gulay Kinikli & Murat Duman

  2. Department of Genetics, School of Medicine, Ankara University, Ankara, Turkey

    Timur Tuncalı & Basak Yalcin Burhan

  3. Department of Nephrology, School of Medicine, Ankara University, Ankara, Turkey

    Sim Kutlay & Sehsuvar Erturk

  4. Sok. 22/50 Manolya Apt. Sogutozu, 06520, Ankara, Turkey

    Nuran Turkcapar

Authors
  1. Nuran Turkcapar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timur Tuncalı
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sim Kutlay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Basak Yalcin Burhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gulay Kinikli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sehsuvar Erturk
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Murat Duman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nuran Turkcapar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Turkcapar, N., Tuncalı, T., Kutlay, S. et al. The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever. Rheumatol Int 27, 545–551 (2007). https://doi.org/10.1007/s00296-006-0255-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-006-0255-8

Keywords

Search

Navigation